[在IQSEC2相关的性脑病症中使用帕兰治疗]
R G Gamirova1, R R Gamirova2, E A Gorobets1
1Kazan (Volga region) Federal University, Kazan, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|March 6, 2025
概括
在IQSEC2基因的突变导致严重的发育障碍. 使用帕拉曼尼尔的新型治疗方法有助于在患有IQSEC2基因突变的患者中管理耐药性性脑病变.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
背景情况:
- IQSEC2基因的突变与神经发育障碍有关,包括脑病,智力障碍和自闭症谱系障碍.
- IQSEC2蛋白对突触功能,学习和记忆至关重要,其功能障碍可能导致严重的神经障碍.
- 早期发病的耐药性是IQSEC2相关疾病的标志,经常导致发育回归.
研究的目的:
- 报告一个患有 de novo IQSEC2 突变,呈现严重神经发育和现象的患者的临床病例.
- 通过下一代测序来调查患者病情的遗传基础.
- 在此背景下,评估佩拉曼奈尔作为抗药性的附加疗法的疗效.
主要方法:
- 使用下一代测序来识别遗传突变.
- 系统地收集和分析了临床数据,包括发作类型,发育状态和治疗反应.
- 患者的是通过托皮拉和佩拉曼尼尔的组合来管理的.
主要成果:
- 在IQSEC2基因中发现了一种半身,X链,de novo突变 (chrX:53241815C>T; c.2984G>A; p.Arg995Gln) 是病人的病因.
- 患者表现出严重的耐药性脑病变,智力障碍,自闭症谱系障碍,形特征和言语缺失.
- 添加帕拉曼尼尔和托皮拉导致了性发作缓解,包括控制焦点和双边强力-克隆性发作,以及性和强力发作.
结论:
- 这一案例凸显了IQSEC2在神经发育和突触功能中的重要作用.
- 对IQSEC2突变的遗传鉴定对于诊断复杂的神经发育障碍至关重要.
- 佩拉曼奈尔在治疗与IQSEC2基因突变相关的严重耐药性方面显示出潜在的有效性.
更多相关视频
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.1K
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
17.1K
相关概念视频
01:14Antiepileptic Drugs: Glutamate Antagonists
267
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
267
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
306
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
306